Exin Therapeutics YC 申请

Winter 2025Active

Exin Therapeutics 在 Winter 2025 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Winter 2025
行业: HealthcareTherapeutics
团队规模: 9
状态: Active
已发布: 2025

创始人

Gabriel Ocana SanteroFounder
Marko TvrdicFounder

Exin Therapeutics 做什么

We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house. We are 3 Oxford-trained neuroscientists supported by an experienced SAB from Harvard, Science Corp (ex-Neuralink), EPFL, Meta, and UCL. In 1.5 months since landing in SF, we went from nothing to (1) opening and operating an animal lab in South SF, (2) obtaining a proof-of-concept in mice, (3) building a multimodal AI model that directs our screening approach and (4) submitting two provisional patents; all while utilizing less than 50% of our YC funding.

Exin Therapeutics 的 YC 申请，重建版

Y Combinator 申请

Exin Therapeutics，Winter 2025 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Exin Therapeutics

Describe what your company does in 50 characters or less.

AI drug discovery platform for neurotherapeutics

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI-driven platform that analyzes high-density multimodal mouse data to discover drugs that modify neural activity. Initially, we target epilepsies associated with autism and Parkinson's disease, but our approach could extend to other neurological disorders involving dysfunctional neural activity.

Where do you live now, and where would the company be based after YC?

We live in San Francisco, CA, and the company is based here post-YC.

Explain your decision regarding location.

We are in San Francisco to be close to biotech investors, collaborators, and research talent. Setting up an animal lab here allows fast iteration between AI insights and in vivo validation, which is key for our approach.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Exin Therapeutics 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Exin Therapeutics 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Exin Therapeutics 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Exin Therapeutics 是哪个 YC 批次的？

Exin Therapeutics 是 Y Combinator Winter 2025 批次的成员。

谁创立了 Exin Therapeutics？

Exin Therapeutics 由 Gabriel Ocana Santero, Marko Tvrdic 创立。

Exin Therapeutics 做什么？